
Key challenges in 3D screening—such as model quality, focus, and tracking treatment-response trajectories—limit the ability to support new approach methodology (NAM)-relevant drug discovery.
This application note details an optimized, high-throughput workflow for characterizing three-dimensional (3D) cell culture models (spheroids) by combining automated kinetic imaging with orthogonal endpoint viability analysis using the Agilent BioTek Cytation 9 cell imaging multimode reader.
Takeaways
Download the whitepaper to learn more.

DOWNLOAD THIS APPLICATION NOTE

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!